Novel TCA circuit enables high-contrast imaging of microRNA in cancer cells, suggesting improved methodologies for assessing drug resistance.
Localized DNA circuits have emerged as a powerful platform for real-time visualization of disease-associated biomolecules in living cells, enabling deeper insights into complex biological processes. However, their extensive applications have been limited by a low probe utilization efficiency and nonspecific background signals. Here, we present a cell-specifically triggered localized catalytic assembly (TCA) circuit designed for high-contrast, reliable imaging of microRNAs (miRNAs). The TCA system features a modular architecture in which an aptamer-mediated targeting module and an endogenously activated sensing module are integrated into a single multifunctional probe. This design enables sequential targeted delivery, target-induced probe activation, and localized sensing of the intracellular miRNA. The integrated strategy significantly improves the probe utilization efficiency and reaction kinetics while suppressing off-target background signals. As a result, it enables high-contrast, accurate imaging of miRNAs and precise discrimination between cancerous and normal cells. Furthermore, we demonstrate its utility in reliably assessing chemotherapy-induced drug resistance in cancer cells. Thus, the TCA circuit provides a robust platform for intracellular biomolecular monitoring and probing of drug-resistance-related molecular mechanisms, highlighting its potential applications in molecular diagnostics and precision medicine.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: